Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy

Kaderli B., Avci R., Yucel A., Guler K., Gelisken O.

JOURNAL OF NEURO-OPHTHALMOLOGY, vol.27, no.3, pp.164-168, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3
  • Publication Date: 2007
  • Doi Number: 10.1097/wno.0b013e31814a5a9a
  • Journal Name: JOURNAL OF NEURO-OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.164-168
  • Bursa Uludag University Affiliated: No

Abstract

Background: The visual outcome in untreated non-arteritic anterior ischemic optic neuropathy (NAION) is dismal. Because intravitreal triamcinolone (IVTA) has shown promise in improving edematous retinal disorders, a pilot trial of this therapy in NAION was considered reasonable.